Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Agios Pharmaceuticals patents

Patents where

Current Assignee

Name

Agios Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9738625 Therapeutically active compounds and their methods of use	Patent 9738625 was granted and assigned to Agios Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9738625	August 22, 2017
‌ US Patent 11040036 Pyruvate kinase activators for use in treating blood disorders	Patent 11040036 was granted and assigned to Agios Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	11040036	June 22, 2021
‌ US Patent 9474779 Therapeutically active compositions and their methods of use	Patent 9474779 was granted and assigned to Agios Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9474779	October 25, 2016
‌ US Patent 9732062 Therapeutically active compounds and their methods of use	Patent 9732062 was granted and assigned to Agios Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9732062	August 15, 2017
‌ US Patent 9656999 Therapeutically active compounds and their methods of use	Patent 9656999 was granted and assigned to Agios Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9656999	May 23, 2017
‌ US Patent 9579324 Therapeutically active compounds and their methods of use	Patent 9579324 was granted and assigned to Agios Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9579324	February 28, 2017
‌ US Patent 9850277 Therapeutically active compositions and their methods of use	Patent 9850277 was granted and assigned to Agios Pharmaceuticals on December, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9850277	December 26, 2017
‌ US Patent 10172864 Therapeutically active compounds and their methods of use	Patent 10172864 was granted and assigned to Agios Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	10172864	January 8, 2019
‌ US Patent 9724350 N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer	Patent 9724350 was granted and assigned to Agios Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9724350	August 8, 2017
‌ US Patent 10329298 Inhibitors of cellular metabolic processes	Patent 10329298 was granted and assigned to Agios Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	10329298	June 25, 2019
‌ US Patent 10029987 Therapeutic compounds and compositions	Patent 10029987 was granted and assigned to Agios Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	10029987	July 24, 2018
‌ US Patent 8742119 Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use	Patent 8742119 was granted and assigned to Agios Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.		Agios Pharmaceuticals	United States Patent and Trademark Office	8742119	June 3, 2014
‌ US Patent 11458127 Methods of treating brain tumors using combination therapy			Agios Pharmaceuticals	United States Patent and Trademark Office	11458127	October 4, 2022
‌ US Patent 9199968 Therapeutic compounds and compositions	Patent 9199968 was granted and assigned to Agios Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.		Agios Pharmaceuticals	United States Patent and Trademark Office	9199968	December 1, 2015
‌ US Patent 10294215 Therapeutically active compounds and their methods of use	Patent 10294215 was granted and assigned to Agios Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	10294215	May 21, 2019
‌ US Patent 9694013 Therapeutically active compounds and their methods of use	Patent 9694013 was granted and assigned to Agios Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9694013	July 4, 2017
‌ US Patent 11234976 Methods of using pyruvate kinase activators	Patent 11234976 was granted and assigned to Agios Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	11234976	February 1, 2022
‌ US Patent 11464775 Pyruvate kinase modulators and use thereof	Patent 11464775 was granted and assigned to Agios Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	11464775	October 11, 2022
‌ US Patent 11364240 Pyruvate kinase activators for use in treating blood disorders	Patent 11364240 was granted and assigned to Agios Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	11364240	June 21, 2022
‌ US Patent 9512107 Therapeutically active compositions and their methods of use	Patent 9512107 was granted and assigned to Agios Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9512107	December 6, 2016
‌ US Patent 8883438 Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1	Patent 8883438 was granted and assigned to Agios Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.		Agios Pharmaceuticals	United States Patent and Trademark Office	8883438	November 11, 2014
‌ US Patent 9856279 Therapeutically active compositions and their methods of use	Patent 9856279 was granted and assigned to Agios Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9856279	January 2, 2018
‌ US Patent 9751863 Therapeutically active compounds and their methods of use	Patent 9751863 was granted and assigned to Agios Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9751863	September 5, 2017
‌ US Patent 9980961 Pyruvate kinase activators for use in therapy	Patent 9980961 was granted and assigned to Agios Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9980961	May 29, 2018
‌ US Patent 9682080 Pyruvate kinase activators for use in therapy	Patent 9682080 was granted and assigned to Agios Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.	Agios Pharmaceuticals	Agios Pharmaceuticals	United States Patent and Trademark Office	9682080	June 20, 2017

Results per page:

88 results

0 selected

88 results

0 selected